Friday, 13 November 2026 Updated 1 hr ago 2,070 stories Sources RSS

The Wire

The financial desks we read, gathered in one place. Stories we are licensed to carry are reproduced in full with the writer credited; everything else is a headline and a short quotation that links straight to the publisher.

Filed by Yahoo Finance — Headlines All sources

In brief

Yahoo Finance Markets Full text

Here’s Why The Fund Trimmed Ross Stores (ROST) in Q2

Madison Investments, an investment advisor, released its second-quarter 2026 investor letter for the “Madison Mid Cap Fund”. You can download a copy of the letter here. U.S. stock market indices posted their strongest second-quarter…

Here’s Why The Fund Trimmed Ross Stores (ROST) in Q2

Yahoo Finance Markets Full text

Billionaire Ken Fisher Was Buying These 2 Cathie Wood Stocks

Q2 13F filings show that billionaire Ken Fisher’s Fisher Asset Management opened new positions in CRISPR Therapeutics (NASDAQ: CRSP) and Coinbase Global (NASDAQ: COIN). Fisher’s fund bought 77,960 CRISPR Therapeutics shares valued at about…

Billionaire Ken Fisher Was Buying These 2 Cathie Wood Stocks

Yahoo Finance Markets Full text

Robust Results Lifted Waters (WAT)

Robust Results Lifted Waters (WAT)WAT Trade Waters on Coinbase Trading disclosure The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or…
Robust Results Lifted Waters (WAT)

Yahoo Finance Markets Full text

Is Medical Properties Trust (MPT) Finally Fixing Its Balance Sheet?

For years, Medical Properties Trust (NYSE:MPT) has operated under a cloud of debt scrutiny, prompting a careful examination of its underlying fundamentals, asset quality, and capital allocation strategy. As a specialized real estate…

Yahoo Finance Markets Full text

Can Applied Aerospace (AADX) Turn Record Backlog Into Real Profit?

In the specialized market of advanced aerospace and defense manufacturing, long-term shareholder value is fundamentally driven by multi-year program visibility, operating leverage, and disciplined portfolio expansion. Applied Aerospace &…

Can Applied Aerospace (AADX) Turn Record Backlog Into Real Profit?

Yahoo Finance Markets Full text

Is Ocular Therapeutix (OCUL) Stock a Buy Ahead of Its Major NDA Catalyst?

In the high-stakes realm of clinical-stage biotechnology, long-term shareholder value is fundamentally forged by pipeline assets that solve deep-seated clinical bottlenecks while offering significant pricing power and capital efficiency…

Is Ocular Therapeutix (OCUL) Stock a Buy Ahead of Its Major NDA Catalyst?
More stories

Stories marked Full text are reproduced here under the terms their publisher allows, with the writer credited and the original linked. Everything else is a headline and a short quotation that links straight to the publisher. How we quote · Our sources